Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Presbia PLCLENS · Entity 160670 | Chief Clinical Officer | February 12, 2018 | February 21, 2018 |
| STAAR SURGICAL COSTAA · Entity 4851 | Chief Development Officer | August 14, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Presbia PLC
Report date February 12, 2018 · Filed February 21, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2018-02-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 50,000 F1: On March 14, 2017, the Reporting Person was granted 50,000 restricted stock units, which will be settled in ordinary shares, par value U.S. $0.001. The restricted stock units vest upon achieving certain future stock price thresholds; provided, however, that in no event shall such restricted stock units vest on a date prior to March 14, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 14, 2017, the Reporting Person was granted 50,000 restricted stock units, which will be settled in ordinary shares, par value U.S. $0.001. The restricted stock units vest upon achieving certain future stock price thresholds; provided, however, that in no event shall such restricted stock units vest on a date prior to March 14, 2018.
STAAR SURGICAL CO
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,599 |
Reported balance
After 2026-08-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-14 · Exercise / conversion · Acquired 5,499 · Balance 43,599 F1: Due to clerical errors, the Reporting Person's prior Form-4 filed with the Securities and Exchange Commission on May 12, 2026 incorrectly reported this value as 32,691 shares when the Reporting Person beneficially owned 28,008 shares and the Reporting Person's prior Form 4 filed with the SEC on May 19, 2026 incorrectly reported this value as 46,026 when the Reporting Person beneficially owned 38.100. The values have been corrected herein. |
| Common StockSEC Table I · non-derivative | Direct | 40,802 |
Reported balance
After 2026-08-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-08-14 · Tax withholding · Disposed 2,797 · Balance 40,802 F2: On August 14, 2026, the third tranche of 5,499 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Award Program ("2025 PSU Program") in connection with her annual equity grant vested, of which 2,797 shares were withheld to satisfy taxes. |
| Common StockSEC Table I · non-derivative | Direct | 40,243 |
Reported balance
After 2026-08-14 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-08-14 · Tax withholding · Disposed 559 · Balance 40,243 |
| Common StockSEC Table I · non-derivative | Direct | 41,343 |
Reported balance
After 2026-08-14 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-08-14 · Exercise / conversion · Acquired 1,100 · Balance 41,343 |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-12-31 | Direct | 5,499 |
Reported balance
After 2026-08-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-14 · Exercise / conversion · Acquired 5,499 · Balance 5,499 F3: Represents the settlement of the third tranche of 5,499 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her annual equity grant vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-12-31 | Direct | 1,100 |
Reported balance
After 2026-08-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-14 · Exercise / conversion · Acquired 1,100 · Balance 1,100 F4: Represents the settlement of the third tranche of of 1,100 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her promotion to Chief Development Officer vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. |
Filing footnotes · ownership attribution and instrument terms
F1: Due to clerical errors, the Reporting Person's prior Form-4 filed with the Securities and Exchange Commission on May 12, 2026 incorrectly reported this value as 32,691 shares when the Reporting Person beneficially owned 28,008 shares and the Reporting Person's prior Form 4 filed with the SEC on May 19, 2026 incorrectly reported this value as 46,026 when the Reporting Person beneficially owned 38.100. The values have been corrected herein.
F2: On August 14, 2026, the third tranche of 5,499 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Award Program ("2025 PSU Program") in connection with her annual equity grant vested, of which 2,797 shares were withheld to satisfy taxes.
F3: Represents the settlement of the third tranche of 5,499 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her annual equity grant vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
F4: Represents the settlement of the third tranche of of 1,100 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her promotion to Chief Development Officer vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 1,100 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000011 · ownership.xml · derivative · entry 6 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,100 Underlying: Common Stock · 1,100 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Represents the settlement of the third tranche of of 1,100 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her promotion to Chief Development Officer vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 5,499 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000011 · ownership.xml · derivative · entry 5 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,499 Underlying: Common Stock · 5,499 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents the settlement of the third tranche of 5,499 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her annual equity grant vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 1,100 | $26.18 | $28,798.00 |
DisclosureSEC source: 0001731487-26-000011 · ownership.xml · nonDerivative · entry 4 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 559 | $26.18 | $14,634.62 |
DisclosureSEC source: 0001731487-26-000011 · ownership.xml · nonDerivative · entry 3 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,243 Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 2,797 | $26.18 | $73,225.46 |
DisclosureSEC source: 0001731487-26-000011 · ownership.xml · nonDerivative · entry 2 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,802 F2 · shares: On August 14, 2026, the third tranche of 5,499 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Award Program ("2025 PSU Program") in connection with her annual equity grant vested, of which 2,797 shares were withheld to satisfy taxes. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 5,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000011 · ownership.xml · nonDerivative · entry 1 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Due to clerical errors, the Reporting Person's prior Form-4 filed with the Securities and Exchange Commission on May 12, 2026 incorrectly reported this value as 32,691 shares when the Reporting Person beneficially owned 28,008 shares and the Reporting Person's prior Form 4 filed with the SEC on May 19, 2026 incorrectly reported this value as 46,026 when the Reporting Person beneficially owned 38.100. The values have been corrected herein. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 1,100 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · derivative · entry 12 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,795 Underlying: Common Stock · 1,100 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Represents the settlement of the second tranche of performance stock units awarded under the 2025 PSU Program to the Reporting Person in connection with her promtion to Chief Development Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 2,199 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · derivative · entry 11 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,695 Underlying: Common Stock · 2,199 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Represents the settlement of the first tranche of performance stock units awarded under the 2025 PSU Program to the Reporting Person in connection with her promtion to Chief Development Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 5,499 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · derivative · entry 10 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,496 Underlying: Common Stock · 5,499 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Represents the settlement of the second tranche of performance stock units awarded to the Reporting Person in connection with her annual equity grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 10,997 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · derivative · entry 9 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,997 Underlying: Common Stock · 10,997 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Represents the settlement of the first tranche of performance stock units awarded to the Reporting Person in connection with her annual equity grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 559 | $32.07 | $17,927.13 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · nonDerivative · entry 8 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,783 F4 · shares: On May 15, 2026, the second tranche of 1,100 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her promtion to Chief Development Officer vested, of which 599 shares were withheld to satisfy taxes. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · nonDerivative · entry 7 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,342 Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 1,118 | $32.07 | $35,854.26 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · nonDerivative · entry 6 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,242 F3 · shares: On May 15, 2026, the first tranche of 2,199 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her promtion to Chief Development Officer vested, of which 1,118 shares were withheld to satisfy taxes. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 2,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · nonDerivative · entry 5 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,360 Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 2,431 | $32.07 | $77,962.17 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · nonDerivative · entry 4 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,161 F2 · shares: On May 15, 2026, the second tranche of 5,499 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her annual equity grant vested, of which 2,431 shares were withheld to satisfy taxes. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 5,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · nonDerivative · entry 3 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,592 Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 5,595 | $32.07 | $179,431.65 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · nonDerivative · entry 2 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,093 F1 · shares: On May 15, 2026, the first tranche of 10,997 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") in connection with her annual equity grant vested, of which 5,595 shares were withheld to satisfy taxes . Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 10,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000008 · ownership.xml · nonDerivative · entry 1 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,688 Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 1,680 | $26.69 | $44,839.20 |
DisclosureSEC source: 0001731487-26-000006 · ownership.xml · nonDerivative · entry 1 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,691 F1 · security: Reflects restricted stock units (RSUs) granted to the Reporting Person on May 8, 2023. These RSUs vested as to 1/3 (4,682 shares) on May 8, 2024, 1/3 (4,682 shares) on May 8, 2025, and 1/3 (4,683 shares) on May 8, 2026. On May 8, 2026, 1,680 shares were withheld to satisfy taxes. F2 · balance_after: This amount includes the corrected number of owned securities that was misreported on the Form 4 filed on March 12, 2026 due to a typo (the correct number was 29,688 and not 29,668). Read SEC document |
| March 14, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 2,932 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000002 · ownership.xml · derivative · entry 9 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,866 Underlying: Common Stock · 2,932 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F4 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (2,932 shares) on March 14, 2026, and will vest as to 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028. On March 14, 2026, 1,052 shares were witheld upon vesting to satisfy taxes. F4 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (2,932 shares) on March 14, 2026, and will vest as to 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028. On March 14, 2026, 1,052 shares were witheld upon vesting to satisfy taxes. Read SEC document |
| March 14, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 14,663 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000002 · ownership.xml · derivative · entry 8 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,326 Underlying: Common Stock · 14,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F3 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (14,663 shares) on March 14, 2026, and will vest as to 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028. On March 14, 2026, 5,261 shares were witheld upon vesting to satisfy taxes. F3 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (14,663 shares) on March 14, 2026, and will vest as to 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028. On March 14, 2026, 5,261 shares were witheld upon vesting to satisfy taxes. Read SEC document |
| March 14, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 6,313 | $18.84 | $118,936.92 |
DisclosureSEC source: 0001731487-26-000002 · ownership.xml · nonDerivative · entry 5 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,668 F3 · shares: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (14,663 shares) on March 14, 2026, and will vest as to 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028. On March 14, 2026, 5,261 shares were witheld upon vesting to satisfy taxes. F4 · shares: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (2,932 shares) on March 14, 2026, and will vest as to 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028. On March 14, 2026, 1,052 shares were witheld upon vesting to satisfy taxes. F5 · balance_after: Includes previously granted RSUs, which are subject to future vesting. Read SEC document |
| March 14, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 2,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000002 · ownership.xml · nonDerivative · entry 4 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (2,932 shares) on March 14, 2026, and will vest as to 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028. On March 14, 2026, 1,052 shares were witheld upon vesting to satisfy taxes. Read SEC document |
| March 14, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 14,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000002 · ownership.xml · nonDerivative · entry 3 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (14,663 shares) on March 14, 2026, and will vest as to 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028. On March 14, 2026, 5,261 shares were witheld upon vesting to satisfy taxes. Read SEC document |
| March 13, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 33,838 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000002 · ownership.xml · derivative · entry 7 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,838 Underlying: Common Stock · 33,838 shares Expires not disclosed F6 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (11,279 shares) on March 13, 2027, 1/3 (11,279 shares) on March 13, 2028, and 1/3 (11,280 shares) on March 13, 2029. F2 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (11,279 shares) on March 13, 2027, 1/3 (11,279 shares) on March 13, 2028, and 1/3 (11,280 shares) on March 13, 2029. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 6,178 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000002 · ownership.xml · derivative · entry 6 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,178 Underlying: Common Stock · 6,178 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F1 · derivative.exercise_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, 1/3 (6,178 shares) on March 12, 2026, and will vest as to 1/3 (6,178 shares) on March 12, 2027. On March 12, 2026, 2,216 shares were witheld upon vesting to satisfy taxes. F1 · derivative.expiration_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, 1/3 (6,178 shares) on March 12, 2026, and will vest as to 1/3 (6,178 shares) on March 12, 2027. On March 12, 2026, 2,216 shares were witheld upon vesting to satisfy taxes. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 2,216 | $18.39 | $40,752.24 |
DisclosureSEC source: 0001731487-26-000002 · ownership.xml · nonDerivative · entry 2 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,406 F1 · shares: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, 1/3 (6,178 shares) on March 12, 2026, and will vest as to 1/3 (6,178 shares) on March 12, 2027. On March 12, 2026, 2,216 shares were witheld upon vesting to satisfy taxes. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 6,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001731487-26-000002 · ownership.xml · nonDerivative · entry 1 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, 1/3 (6,178 shares) on March 12, 2026, and will vest as to 1/3 (6,178 shares) on March 12, 2027. On March 12, 2026, 2,216 shares were witheld upon vesting to satisfy taxes. Read SEC document |
| May 08, 2025 Filed May 15, 2025 00:41 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 1,675 | $19.53 | $32,712.75 |
DisclosureSEC source: 0000950170-25-071780 · ownership.xml · nonDerivative · entry 1 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,444 F1 · security: On May 8, 2023, the reporting person was granted an award of 14,047 restricted stock units (RSUs), subject to vesting as to 1/3 of the shares of common stock subject to such RSUs annually over three years. On May 8, 2025, the RSUs vested as to 4,682 shares, and 1,675 shares were withheld to satisfy taxes. F2 · balance_after: Includes shares of common stock owned outright and shares of common stock subject to unvested RSUs. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 8,798 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-041514 · ownership.xml · derivative · entry 2 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,798 Underlying: Common Stock · 8,798 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F3 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with the Reporting Person's promotion to Chief Development Officer. These RSUs vest as to 1/3 (2,932 shares) on March 14, 2026, 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028. F3 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with the Reporting Person's promotion to Chief Development Officer. These RSUs vest as to 1/3 (2,932 shares) on March 14, 2026, 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 43,989 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-041514 · ownership.xml · derivative · entry 1 Michna Magda · CIK 0001731487 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,989 Underlying: Common Stock · 43,989 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with annual equity award. These RSUs vest as to 1/3 (14,663 shares) on March 14, 2026, 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028. F2 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with annual equity award. These RSUs vest as to 1/3 (14,663 shares) on March 14, 2026, 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 23:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 6,177 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-039705 · ownership.xml · derivative · entry 3 Michna Magda · CIK 0001731487 · Chief Clinical, Regulatory, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,356 Underlying: Common Stock · 6,177 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F1 · derivative.exercise_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, and will vest as 1/3 (6,178 shares) on March 12, 2026, and 1/3 (6,178 shares) on March 12, 2027. F1 · derivative.expiration_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, and will vest as 1/3 (6,178 shares) on March 12, 2026, and 1/3 (6,178 shares) on March 12, 2027. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 23:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 2,435 | $18.00 | $43,830.00 |
DisclosureSEC source: 0000950170-25-039705 · ownership.xml · nonDerivative · entry 2 Michna Magda · CIK 0001731487 · Chief Clinical, Regulatory, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,119 F2 · shares: Shares withheld by the Corporation to satisfy tax withholding obligations. F3 · balance_after: Includes previously granted RSUs, which are subject to future vesting. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 23:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 6,177 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-039705 · ownership.xml · nonDerivative · entry 1 Michna Magda · CIK 0001731487 · Chief Clinical, Regulatory, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, and will vest as 1/3 (6,178 shares) on March 12, 2026, and 1/3 (6,178 shares) on March 12, 2027. Read SEC document |
| May 08, 2024 Filed May 9, 2024 21:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 1,670 | $41.02 | $68,503.40 |
DisclosureSEC source: 0000950170-24-057241 · ownership.xml · nonDerivative · entry 1 Michna Magda · CIK 0001731487 · Chief Clinical, Regulatory, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,377 F1 · security: On May 8, 2023, the reporting person was granted an award of 14,047 restricted stock units (RSUs), subject to vesting as to 1/3 of the shares of common stock subject to such RSUs annually over three years. On May 8, 2024, the RSUs vested as to 4,682 shares, and 1,670 shares were withheld to satisfy taxes. F2 · balance_after: Includes shares of common stock owned outright and shares of common stock subject to unvested RSUs. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:16 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 16,599 | $0.00 Strike: $37.64 | $0.00 |
DisclosureSEC source: 0000950170-24-031664 · ownership.xml · derivative · entry 2 Michna Magda · CIK 0001731487 · Chief Clinical, Regulatory, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,599 Underlying: Common Stock · 16,599 shares Expires 2034-03-11 F3 · derivative.exercise_date: Stock options granted to the Reporting Person on March 12, 2024. Options will vest and become exercisable as to 1/3 (5,533 shares) on March 12, 2025, with the remaining 2/3 (11,066 shares) vesting and becoming exercisable monthly over the following 24 months in equal amounts on a monthly basis. In the event such amount does not evenly divide into 24 months, the remaining balance of options will vest and become exercisable on March 12, 2027. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:16 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 18,533 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-031664 · ownership.xml · derivative · entry 1 Michna Magda · CIK 0001731487 · Chief Clinical, Regulatory, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,533 Underlying: Common Stock · 18,533 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: RSUs granted to the Reporting Person on March 12, 2024. RSUs will vest as to 1/3 (6,177 shares) on March 12, 2025, 1/3 (6,177 shares) on March 12, 2026, and 1/3 (6,179 shares) on March 12, 2027. F2 · derivative.expiration_date: RSUs granted to the Reporting Person on March 12, 2024. RSUs will vest as to 1/3 (6,177 shares) on March 12, 2025, 1/3 (6,177 shares) on March 12, 2026, and 1/3 (6,179 shares) on March 12, 2027. Read SEC document |
| May 08, 2023 Filed May 9, 2023 21:26 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 25,955 | $0.00 Strike: $67.63 | $0.00 |
DisclosureSEC source: 0001209191-23-028341 · doc4.xml · derivative · entry 2 Michna Magda · CIK 0001731487 · Chief Clinical, Regulatory, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,955 Underlying: Common Stock · 25,955 shares Expires 2033-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 5/08/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 5/08/2026. Read SEC document |
| May 08, 2023 Filed May 9, 2023 21:26 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 14,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028341 · doc4.xml · nonDerivative · entry 1 Michna Magda · CIK 0001731487 · Chief Clinical, Regulatory, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Award of 14,047 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the shares (4682) on 5/08/24, 1/3 of the shares (4682) on 5/08/25, and 1/3 of the shares (4683) on 5/08/26. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.